Home | List of Topics | General Medical Information | General Adult Health
The hepatitis A vaccine protects you against a type of liver inflammation called hepatitis A. The vaccine will not protect you from other types of hepatitis.
The vaccine, called Havrix or VAQTA, is made from inactivated whole virus of hepatitis A. The inactive virus stimulates your body to produce antibodies against the hepatitis A virus.
The vaccine is given by an injection in your arm. You should be protected against the disease within 2 weeks after receiving the first dose. However, to ensure complete immunization against the disease, two vaccinations are required. After receiving the first vaccination, children and adults should have a booster vaccination in 6 to 12 months.
A vaccine for adults called Twinrix provides protection against both Hepatitis A and B. It is given in 3 doses.
WHO SHOULD BE IMMUNIZED
People who work or travel in areas with high rates of infection should be vaccinated. These areas include Africa, Asia (except Japan), the Mediterranean, Eastern Europe, the Middle East, Central and Southern America, Mexico, and parts of the Caribbean.
If you are traveling to these areas before you are fully immunized (less than 4 weeks after your first shot), you should receive a preventive dose of immunoglobulin (IG). If you are just a short-term traveler to these areas, you may wish to receive the immunoglobulin (IG) instead of the vaccine.
This vaccine is required in children in Alaska, Arizona, Missouri, Nevada, New Mexico, Oklahoma, Tennessee, and Utah. In addition, the Advisory Committee on Immunization Practices recommends (but does not mandate) routine vaccination of all children older than age 1 with two doses of vaccine spaced 6 months apart.
Other people who are at higher risk for hepatitis A include:
WHO SHOULD NOT BE IMMUNIZED
If you have had hepatitis A in the past, you do not need the vaccine. Once you have recovered from the disease, you are immune for life.
Others who should NOT receive the vaccine include:
RISKS
The most common side effect of the vaccine is pain at the injection site. Other rare, but possible, side effects include:
CALL YOUR PRIMARY HEALTH CARE PROVIDER IF:
CDC. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1999;48(No. RR-12).
CDC. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR. 2002;51 (No. RR-2).
Review Date:8/29/2007
Reviewed By:Arnold L. Lentnek, MD, Division of Infectious Disease, Kennestone Hospital, Marietta, GA. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.